Androgen therapy for anaemia of chronic renal failure

Scandinavian Journal of Urology and Nephrology

Volumn 30, Issue 5, 1996, Pages 403-408

  Teruel, José L ^a   Aguilera, Abelardo ^a   Marcen, Roberta ^a   Antolin, Javier Navarro ^a   Otero, Gonzalo Garcia ^a   Ortuño, Joaquín ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Anaemia; Haemodialysis; Nandrolone decanoate

Indexed keywords

ANDROGEN; NANDROLONE DECANOATE;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; COST CONTROL; DRUG COST; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029807008     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365599609181318     Document Type: Article

References (24)

1. Ballal SH, Domoto DT, Polack DC, Marciulonis P, Martin KJ. Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage disease. Am J Kidney Dis 1991; XVII: 29-33.
2. Berns JS, Rudnick MR, Cohen RM. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis. Clin Nephrol 1992; 37: 264-267.
3. Bernstein MS, Hunter RL, Yachnin S. Hepatoma and peliosis hepatis developing in a patient with Fanconi's anemia. N Engl J Med 1971; 284: 1135-1136.
4. Buchwald D, Argyres S, Easterling RE, et al. Effect of nandrolone decanoate on the anemia of chronic hemodialysis patients. Nephron 1977; 18: 232-238.
5. Cattran DC, Fenton SSA, Wilson DR, Oreopoulos D, Shimizu A, Richardson RM. A controlled trial of nandrolone decanoate in the treatment of uremic anemia. Kidney Int 1977; 12: 430-437.
6. Criqui MH, Heiss G, Cohn R, et al. Plasma triglyceride level and mostality from coronary heart disease. N Eng J Med 1993; 328: 1220-1225.
7. Davies M, Muckle TJ, Cassells-Smith, Webster D, Kerr DNS. Oxymetholone in the treatment of anemia in chronic renal failure. Br J Urol 1972; 44: 387-394.
8. DeGowin RL, Lavender AR, Forland M, Charleston D, Gottschalk A. Erythropoiesis and erythropoietin in patients with chronic renal failure treated with hemodialysis and testosterone. Ann Intern Med 1970; 72: 913-918.
9. Eschbach JW, Adamson JW. Improvement in the anemia of chronic renal failure with fluoxymesterone. Ann Intern Med 1973; 78: 527-532.
10. Fried W, Jonason O, Lang G, Schwartz F. The hematologic effect of androgen in uremic patients. Study of packed cell volume and erythropoietin responses. Ann Intern Med 1973; 79: 823-827.
11. von Hartitzsch B, Kerr DNS, Morley G, Marks B. Androgens in the anaemia of chronic renal failure. Nephron 1977; 18: 13-20.
12. Hendler ED, Goffinet JA, Ross S, Longnecker RE, Bakovic V. Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis. N Engl J Med 1974; 291: 1046-1051.
13. Johnson FL, Feagler JR, Lerner KG, et al. Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet 1972; 2: 1273-1276.
14. Kalmanti M, Dainiak N, Martino J, Dewey M, Kulkarni V, Howard D. Correlation of clinical and in vitro erythropoietic responses to androgens in renal failure. Kidney Int 1982; 22: 383-391.
15. Mirahmadi MK, Vaziri ND, Gorman JT. Controlled evaluation of hemodialysis patients on nandrolone decanoate (ND) vs testosterone enanthate (TE). Trans Am Soc Artif Intern Organs 1979; 25: 449-453.
16. Naik RB, Gibbons AR, Gyde OHB, Harris BR, Robinson BHB. Androgen tria in renal anemia (Abstract). Kidney Int 1978; 14: 109.
17. Neff MS, Goldberg J, Slifkin RF, et al. A comparison of androgens for anemia in patients on hemodialysis. N Engl J Med 1981; 304: 871-875.
18. Parker PA, Izard MW, Maher JF. Therapy of iron deficiency in patients on maintenance dialysis. Nephron 1979; 23: 181-186.
19. Pascual J, Teruel JL, Marcén R, Liaño F, Ortuño J. Blood pressure after three different forms of correction of anemia in hemodialysis. Int J Artif Organs 1992; 15: 393-396.
20. Richardson JR Jr, Weinstein MB. Erythropoietic response of dialyzed patients to testosterone administration. Ann Intern Med 1970; 73: 403-407.
21. Shaldon S, Koch KM, Oppermann F, Patyna WD, Schoeppe W. Testosterone therapy for anaemia in maintenance dialysis. Br Med J 1971; 3: 212-214.
22. Teruel JL, Quereda C, Martin E, Orofino L, Liaño F, Ortuño J. Tratamiento de la anemia no ferropénica en hemodiálisis mediante anabolizantes. Nefrologia 1983; III: 273-278.
23. Williams JS, Stein JH, Ferris ThH. Nandrolone decanoate therapy for patients receiving hemodialysis. Arch Intern Med 1974; 134: 289-292.
24. Zevin D, Turani H, Cohen A, Levi J. Androgen-associated hepatoma in a hemodialysis patient. Nephron 29: 274-276, 1981.